Home › Drug Product Listings

Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (37) | B (20) | C (24) | D (37) | E (40) | F (12) | G (11) | H (9) | I (24) | K (1) | L (26) | M (12) | N (7) | O (12) | P (28) | R (14) | S (27) | T (33) | U (4) | V (13) | W (2) | Z (4)
Generic Name Common Trade Name(s)sort icon Classification Date Marketed in Canada (yyyy/mm/dd)
Hydrocodone + phenylephrine + pyrilamine + ammonium chloride Hycomine Syrup Narcotic 2011/05/11
Hydromorphone hydrochloride Hydromorph Contin Opioid analgesic 2011/04/01
Aluminum chloride hexahydrate Hydrosal gel Antiperspirant
Tenapanor Ibsrela Sodium/hydrogen exchanger inhibitor 2020/11/23
Enasidenib IDHIFA Antineoplastic agent / IDH2 Inhibitor 2019/02/27
Canakinumab Ilaris Immunomodulatory agent - selective interleukin-1 beta inhibitor 2010/05/03
Telaprevir Incivek Antiviral agent 2011/10/06
Indomethacin Indomethacin P.D.A. NSAID 2011/11/15
Cilazapril Inhibace ACE inhibitor
Axitinib Inlyta Anti-tumor agent 2012/09
Tiotropium + olodaterol Inspiolto Respimat Bronchodilator combination - LAMA plus LABA 2015/05/29
Eplerenone Inspra Aldosterone antagonist 2009/02/26
Influenza Vaccine Intanza Vaccine 2010/08/01
Guanfacine HCl Intuniv XR Alpha adrenergic receptor agonist for ADHD 2013/08/06
Paliperidone Invega Antipsychotic agent 2007/10/02
Paliperidone palmitate Invega Sustenna Antipsychotic agent 2010/07/28
Canagliflozin Invokana antihyperglycemic agent 2014/06/25
Homatropine Isopto Homatropine Mydriatic agent
White birch extract (Betula verrucosa) Itulatek Allergy immunotherapy 2020/09/28
Ruxolitinib Jakavi Antineoplastic agent 2012/07/18
Dutasteride + tamsulosin Jalyn Alpha-1 blocker + 5-Alpha reductase inhibitor 2012/02/03
Tamsulosin + dutasteride Jalyn Alpha-1 blocker + 5-Alpha reductase inhibitor 2012/02/03
Sitagliptin and metformin Janumet Hypoglycemic agent 2009/09/24
Sitagliptin Januvia Hypoglycemic agent 2012/11/20
Empagliflozin Jardiance Sodium-glucose contransporter 2 (SGLT2) inhibitor 2015/08/11
Levonorgestrel Jaydess Intrauterine System Progestogen 2013/11/01
Linagliptin + metformin Jentadueto Oral antihyperglycemic agent 2013/04/17
Cabazitaxel Jevtana Antineoplastic agent 2011/06
Tolvaptan Jinarc Vasopressin V2-receptor antagonist 2015/06/01
Hydromorphone hydrochloride Jurnista opioid anaglesic 2010/04/13
Trastuzumab emtansine Kadcyla Antineoplastic agent 2013/09/27
Ivacaftor Kalydeco Cystic fibrosis transmembrane conductance regulator potentiator 2012/12/01
Alogliptin + metformin Kazano Oral antihyperglycemic agent 2014/10/08
Ofatumumab Kesimpta Immunomudulator 2021/04/08
Sarilumab Kevzara Disease modifying anti-rheumatic drug 2017/08/16
Ribociclib Kisqali Antineoplastic agent 2018/11/26
Syndicate content